KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Debt Ratio for 4 consecutive years, with 0.07 as the latest value for Q1 2020.

  • On a quarterly basis, Debt Ratio fell 49.96% to 0.07 in Q1 2020 year-over-year; TTM through Mar 2020 was 0.07, a 49.96% decrease, with the full-year FY2019 number at 0.11, changed N/A from a year prior.
  • Debt Ratio was 0.07 for Q1 2020 at Xenon Pharmaceuticals, down from 0.11 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.18 in Q1 2018 to a low of 0.07 in Q1 2020.
  • A 4-year average of 0.14 and a median of 0.14 in 2019 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: skyrocketed 36.47% in 2019, then plummeted 49.96% in 2020.
  • Xenon Pharmaceuticals' Debt Ratio stood at 0.15 in 2017, then decreased by 22.65% to 0.11 in 2018, then fell by 7.8% to 0.11 in 2019, then tumbled by 37.14% to 0.07 in 2020.
  • Per Business Quant, the three most recent readings for XENE's Debt Ratio are 0.07 (Q1 2020), 0.11 (Q4 2019), and 0.16 (Q3 2019).